TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/31/2026
Back to search
Official data from USPTO
AMPLI1
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
08/01/2026
Trademark type
Combined
Nice classes
1, 5
Filing date
02/02/2021
Registration date
01/18/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/18/2022
Last transaction
08/01/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
09
Owner location
IT
Examiner
NOVAKOVIC, MIROSLAV
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "AMPLI1" in stylized font.
Holders and representatives
Holders
Menarini Silicon Biosystems S.p.A.
Representatives
Arthur DeBaugh Allman Spry Leggett Crumpler & Horn, P.A.
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical reagents for molecular biology not for medical or veterinary purposes; reagents for use in scientific apparatus for chemical analysis; reagents for scientific use; reagents for medical research use; genetic identity tests comprised of reagents for non-medical purposes; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria other than for medical or veterinary purposes; nucleic acid sequencing programs other than for medical and veterinary purposes; reagents for research purposes; laboratory reagents for scientific use; nucleic acid amplification reagents other than for medical and veterinary purposes; insemination result control diagnostic reagents for scientific use
Class 5
Diagnostic kits composed of diagnostic agentspreparations and substances for medical use in disease testing; diagnostic preparations and materialsdiagnostic preparations for medical and veterinary use; diagnostic preparations for medical purposes; diagnostic chemical reagents for medical purposes; clinical medical reagents; clinical diagnostic medical reagents; diagnostic biomarker reagents for medical purposes; reagents for use in diagnostic tests for medical purposes; nucleic acid sequences for medical and veterinary purposes; reagents for in-vitro laboratory use being reagents for medical purposes
Publications
History of USPTO decisions and trademark events.
28 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/31/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/31/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/12/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/12/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/12/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/18/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/29/2022
FIMP
FINAL DISPOSITION PROCESSED
06/29/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/18/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/18/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/02/2021
PUBO
PUBLISHED FOR OPPOSITION
11/02/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/13/2021
RFNT
REFUSAL PROCESSED BY IB
10/04/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/25/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/24/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/23/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/15/2021
RFRR
REFUSAL PROCESSED BY MPU
09/15/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/02/2021
CNRT
NON-FINAL ACTION WRITTEN
09/01/2021
DOCK
ASSIGNED TO EXAMINER
08/24/2021
MAFR
APPLICATION FILING RECEIPT MAILED
05/14/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/10/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/10/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/08/2021
Continuous trademark protection
Get notified about every new filing that threatens AMPLI1 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.